The Diversified Offerings of 9 Transgenic Animal Strains Platforms supports Solid Growth in Drug Discovery Services VICTORIA, May 29, 2019 / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) announces that its proprietary, high-throughput B-cell and phage display platforms have garnered a lot of attention as of late, and … Continue reading